The landscape of practice management and coding methodologies continues to be challenging in the current healthcare environment, and rheumatology practices must maintain focus on managing an effective and efficient practice. Join us at the 2017 ACR/ARHP Annual Meeting, Nov. 3–8 in San Diego, and gain knowledge and understanding of best practices in an ever-changing environment…
With a shortage of rheumatologists in the U.S. already a problem and projected to get far worse, the ACR is advocating for the passage of a variety of laws that would help narrow the gap. Legislation being fought for by ACR advocacy leaders involves streamlining visa processing for foreign physicians and promoting incentives for physicians…
NEW YORK (Reuters Health)—The investigational drug romosozumab led to gains in hip bone mineral density (BMD) that were not seen with teriparatide in older women with osteoporosis transitioning from bisphosphonate therapy in the STRUCTURE study. Amgen’s romosozumab is a monoclonal antibody that inhibits sclerosin, a negative regulator of bone formation. In addition to stimulating bone…
A 2017 survey showed that rheumatologists’ pay has plateaued. And according to Anne Bass, MD, many cognitive fields, such as pediatrics and endocrinology, remain underpaid due to the current reimbursement structure…
WASHINGTON (Reuters)—U.S. Senate Republicans embarked on Thursday on another push to unravel Obamacare, working on a stripped-down bill after failing to pass broader legislation and complete a seven-year campaign to gut a law that extended health coverage to millions. Republicans leaders hope a so-called skinny bill can draw enough votes to pass despite unified Democratic…
WASHINGTON (Reuters)—After a months-long struggle, Republicans have succeeded in bringing Obamacare repeal legislation, a centerpiece of their 2016 election campaigns, to a debate on the U.S. Senate floor. Now the hard part begins. Republicans, deeply divided over the proper role of the government in helping low-income people receive healthcare, eked out a procedural win on…
A new guideline developed by the ACR and the American Association of Hip and Knee Surgeons addresses the perioperative use of antirheumatic drug therapy. Specifically, it provides recommendations on the use of traditional disease-modifying antirheumatic drugs, biologic agents, tofacitinib and glucocorticoids in adults with RA; SpA, including ankylosing spondylitis and psoriatic arthritis; JIA; or SLE undergoing elective THA or TKA. The guideline provides recommendations regarding when to continue, when to withhold and when to restart these medications, and the optimal perioperative dosing of glucocorticoids…
The AMA House of Delegates (HOD) met in Chicago for its annual meeting June 9–14. More than 530 HOD members were present, with several hundred AMA and association staff and guests. As I am sure you have noted from past issues of ACR@Work, the ACR is in its five-year membership review. The ACR must be…
Believe it or not, change begins with one person willing to lead by example—and you can be that person. All too often, we get caught up with the changes we want. However, instead of talking about what we would like, it’s time to lead. The best way to do this is to show others you’re…
Members’ voices are crucial to making an impact on policies that have an impact on healthcare. Here, we’d like to thank members who have invested in the first half of this year, yielding $16,000 more than was raised over the same time period last year. In response to an in-depth examination of RheumPAC in 2016,…